NeoGenomics Laboratories, Inc. provides cancer diagnostics and pharma services to oncologists, pathologists, pharmaceutical companies, academic centers, and others. It offers hematopathology, solid tumor, tumor profile, liquid biopsy, hereditary cancer, and women's health testing services through cytogenetic, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry and in situ hybridization, and molecular methodologies. The company was founded in 2001 and is based in Fort Myers, Florida. It has locations in Nashville, Tennessee; Houston, Texas; and Irvine, Fresno, and Aliso Viejo, California.